We proudly announce the Crystal Pharmatech Formulation Forum, providing an educational platform with monthly webinars for fellow formulators and the pharmaceutical industry as a whole.
From these monthly webinars, we offer scientists and innovators access to:
Presentations by leading formulators from different organizations and academia throughout the industry
Live sessions to ask questions and engage with presenters
Dialogue between experts to dive deep into complex subject matter
In this series, we will discuss how it is possible to accelerate from Candidate Selection to Phase I FIH cost effectively, within 12 months, and with visibility into future clinical trials. A recent survey of 150 biopharmaceutical development scientists concludes:
Formulation issues have led to project failure and significant delays for about 60% of responding companies.
Of those projects, a delay of more than 12 months was reported by 52%
10% experienced complete failure
This study's findings highlight the importance of first-time-right development to avoid costly delays.
Crystal Pharmatech is pleased to announce a webinar series on 'Selecting the Right API Form and Formulation'. Choosing the right form and formulation is a continuously evolving field. To stay at the cutting edge of this field internally and continuously educate the community externally, Crystal Pharmatech has gathered a panel of distinguished scientists from various disciplines to support our 'Crystal Clear Pathways to Select API Form and Formulation'. The panel serves to educate pharmaceutical companies on the importance of the proper selection of API phase and formulation. This panel has combined to assess the form and formulation for hundreds of development compounds. Experiencing it all, they've seen the successes and the horror stories of development and are now willing to share them with you through case studies, panel discussions, and webinars.
Crystal Pharmatech is pleased to announce our new webinar series: "Molecules-to-Medicine: Accelerating Drug Development through Collaboration". Purpose: To communicate the extraordinary ingenuity taking place in 21st century drug discovery and development and that a good idea is just the first step in creating a medicine. In a nutshell, why CMC matters and how collaboration can accelerate development. Presenters: Innovative pharmaceutical scientists and entrepreneurs showcasing novel therapeutic technologies with a focus on how a molecule becomes a medicine.
Subscribe to be the first to get the updates!
